Payload-Linker Services For Antibody Drug Conjugates

Antibody-drug conjugates (ADCs) are transforming oncology treatments for patients worldwide. However, their complexity requires specialized expertise and facilities. SK pharmteco specializes in the development and manufacturing of ADC linkers and payloads, backed by leading chromatography purification and analytical testing capabilities.

To meet growing demands, SK pharmteco is expanding its high-potency capacity with a new small-scale CGMP kilo lab, coming online in Q4 2025. Capable of handling HPAPIs with an OEL down to 10 ng/m³, this facility complements SK pharmteco’s existing laboratories and manufacturing plant, enabling ADC payload and linker production from clinical to commercial scale.

Download the one-pager to learn how SK pharmteco can help advance your ADC payloads and linkers with confidence.